[Methotrexate treatment before use of biologics in rheumatoid arthritis : Analysis of guideline compliance].
Nicolas PardeyJan ZeidlerTim Fritz NellenschulteJona T StahmeyerKirsten HoeperTorsten WittePublished in: Zeitschrift fur Rheumatologie (2021)
Targeted use of the full spectrum of therapies provided prior to initiation of bDMARD treatment may contribute to cost-effective RA care. This study showed indications for potential deficits in outpatient MTX prescription practice and can raise awareness for efficient treatment.